Private equity firm TPG is reportedly working with investment bankers from JPMorgan Chase to explore a potential sale of Lyric, a healthcare payments software company. The discussions are focused on finding a buyer for the business, with an estimated valuation of $5 billion.
Lyric provides software solutions for healthcare payments, a sector that has seen increased interest from strategic buyers and larger financial institutions. The potential sale comes as TPG continues to evaluate its portfolio of assets and look for opportunities to divest non-core businesses.
Representatives for TPG and Lyric have not commented on the matter. The process is in the early stages, and there is no guarantee that a transaction will be completed.
